Ultrasound Guided Therapeutic Percutaneous Electrolysis in Achilles Tendinopathy.

Sponsor
Hospital Universitario Infanta Leonor (Other)
Overall Status
Recruiting
CT.gov ID
NCT03167554
Collaborator
(none)
96
1
3
79
1.2

Study Details

Study Description

Brief Summary

Achilles tendon is a frequent lower-limb tissue where tendinopathy may arise. Percutaneous Therapeutic Electrolysis (EPTE®) is an electronic device that enables to treat accurately, guided by an ultrasound, the tendon injured area by applying a galvanic current through an acupuncture needle. Thus, the first stage of physiological regenerative process may be obtained. Design: Randomized Controlled Clinical Trial. Objectives: To know the effectiveness of Percutaneous Therapeutic Electrolysis (EPTE®) versus a sham intervention at improving pain and function in patients who undergo Achilles Chronic Tendinopathy and to determine the efficiency of Percutaneous Therapeutic Electrolysis (EPTE®) with monopolar needle versus Percutaneous Therapeutic Electrolysis (EPTE®) with bipolar needle at improving pain and function in patients who undergo Achilles Chronic Tendinopathy. Participants: patients diagnosed with Achilles Chronic Tendinopathy. Setting. Infanta Leonor Hospital, Madrid, Spain. Experimental intervention: Percutaneous Therapeutic Electrolysis (EPTE®) with monopolar needle, 330 microamps, 1 min 20 sec versus bipolar needle. Sham intervention: the guide tube of the needle contacted with the skin and the device remained switched on to simulate its functioning.

Condition or Disease Intervention/Treatment Phase
  • Other: Sham comparator
  • Other: Experimental group 1
  • Other: Experimental group 2
N/A

Detailed Description

Tendinopathy is a common injury among athletes, where the incidence reaches 50%. Nevertheless, industrial workers as well as sedentary subjects may also undergo this pain condition.

Achilles tendon is a frequent lower-limb tissue where tendinopathy may arise. Achilles tendinopathy risk factors have been detailed, such as: age, mechanical axis deviation of lower limbs, excessive training load dosage, and type of work activity. The middle portion of the tendon is the area where Achilles tendinopathy is most likely to be located. Interestingly, correlation between pain severity and the degree of tissue degeneration by imaging diagnosis is hardly showed in chronic tendinopathy conditions. Thus, chronic tendinopathy pain may be mediated not only by peripheral but by central mechanisms.

Percutaneous Therapeutic Electrolysis (EPTE® System; Manual EPTE, 2014 IONCLINICS & DEIONIC, S.L.) is an electronic device that enables to treat accurately, guided by an ultrasound, the tendon injured area by penetrating the skin with an acupuncture needle. A galvanic current goes through the device to the needle so that the first stage of physiological regenerative process may be obtained. That is due to a chemical reaction that leads to a controlled alkaline burn into the injured tissue and a subsequent basification of extracellular medium. That elicits an inflammatory response; the destroyed tissue is metabolized by phagocytosis process. Design: Randomized Controlled Clinical Trial. Objectives: To know the effectiveness of Percutaneous Therapeutic Electrolysis (EPTE®) versus a sham intervention at improving pain and function in patients who undergo Achilles Chronic Tendinopathy, and to determine the efficiency of Percutaneous Therapeutic Electrolysis (EPTE®) with monopolar needle versus Percutaneous Therapeutic Electrolysis (EPTE®) with bipolar needle at improving pain and function in patients who undergo Achilles Chronic Tendinopathy. Participants: patients diagnosed with Achilles Chronic Tendinopathy. Setting. Infanta Leonor Hospital, Madrid, Spain. Experimental intervention: Percutaneous Therapeutic Electrolysis (EPTE®) with monopolar needle, 330 microamps, 1 min 20 sec versus bipolar needle. Sham intervention: the guide tube of the needle contacted with the skin and the electrolysis device remained switched on to simulate its functioning.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
96 participants
Allocation:
Randomized
Intervention Model:
Sequential Assignment
Intervention Model Description:
Randomized controlled clinical trial.Randomized controlled clinical trial.
Masking:
Triple (Participant, Care Provider, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effectiveness of Therapeutic Percutaneous (EPTE®) Guided by Ultrasound as a Treatment of Achilles Tendinopathy. A Randomized Controlled Clinical Trial.
Actual Study Start Date :
May 1, 2016
Anticipated Primary Completion Date :
Aug 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Sham Comparator: Sham group

Simulating of the electrolysis application.he electrolysis technique was simulated to be delivered. The guide tube of the needle contacted with the skin, located on the painful area, and the device remained switched on to simulate its functioning.

Other: Sham comparator
The electrolysis technique was simulated to be delivered. The guide tube of the needle contacted with the skin, located on the painful area, and the device remained switched on to simulate its functioning.
Other Names:
  • Sham group
  • Experimental: Experimental group 1

    Electrolysis application with monopolar needle.

    Other: Experimental group 1
    Percutaneous Therapeutic Electrolysis (EPTE®) with monopolar needle, 330 microamps, 1 min 20 sec.
    Other Names:
  • Electrolysis application with monopolar needle.
  • Experimental: Experimental group 2

    Electrolysis application with bipolar needle.

    Other: Experimental group 2
    Percutaneous Therapeutic Electrolysis (EPTE®) with bipolar needle, 120 microamps, 1 min 20 sec.
    Other Names:
  • Electrolysis application with bipolar needle.
  • Outcome Measures

    Primary Outcome Measures

    1. Pain intensity [5 min]

      Measured by Numeric Pain Rating Scale. Punctuation from 0 point up to 10 points. "0" no pain; "10" the most bearable pain.

    Secondary Outcome Measures

    1. Lower limb functionality [10 min]

      Measured by Visa-A Scale. Punctuation from 0 point up to 100 points. "0"point the most inability; "100" points complete functionality.

    2. Achilles tendon thickening [5 min]

      Assessed by ultrasonography. Thickening was considered when the thickness is 50% greater than the contralateral limb.

    3. Length of the most thickened area [5 min]

      Assessed by ultrasonography. Distance (in mm) between the two extremes of the thickened area

    4. Location of the most thickened area [5 min]

      Assessed by ultrasonography. Distance (in mm) from the Achilles insertion up to the thickening onset.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Achilles Chronic Tendinopathy diagnosis (from 3months up to 3 years)
    Exclusion Criteria:
    • Physical therapy treatment within the last 4 months.

    • Surgery approach for Achilles tendinopathy.

    • Pregnancy

    • Corticoid treatment in the last 4 months.

    • Pacemaker

    • Thrombophlebitis

    • Systemic disease

    • Cognitive disease

    • Prosthesis or osteosynthesis

    • Dermatopathies

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hospital Universitario Inflanta Leonor Madrid Spain

    Sponsors and Collaborators

    • Hospital Universitario Infanta Leonor

    Investigators

    • Principal Investigator: Javier Herraiz Garvin, MSc, Hospital Universitario Infanta Leonor

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Hospital Universitario Infanta Leonor
    ClinicalTrials.gov Identifier:
    NCT03167554
    Other Study ID Numbers:
    • HUILeonor
    First Posted:
    May 30, 2017
    Last Update Posted:
    Mar 18, 2022
    Last Verified:
    Feb 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 18, 2022